CATO PHARMA ApS: Financial statements 2020
CVR: 33949596
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CATO PHARMA ApS (CVR 33949596) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK -352 compared with DKK -588 the year before. Equity in the 2020 report amounted to DKK -280,326.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -352
- Equity
- DKK -280,326
- Total Assets
- DKK 4,025
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | 0 | -352 | -280 t. | - |
| 2019 | - | - | -588 | -280 t. | - |
| 2018 | - | - | -6 t. | -279 t. | - |
| 2017 | 0 | 0 | -539 | -274 t. | - |
| 2016 | 0 | -750 | -848 | -273 t. | - |
Official annual report
How creditworthy is CATO PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CATO PHARMA ApS has published its annual report for 2019. The net result was DKK -588.
About CATO PHARMA ApS
CATO PHARMA ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2011. The company has been dissolved. The company was registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. In 2024, the company reported a net result of DKK -1,668 compared with DKK -1,588 the year before. Equity in the 2024 report amounted to DKK -283,700.